ABSTRACT
Arterial stiffness is a cardiovascular risk factor and dramatically increases as women transition through menopause. The current study assessed whether a mouse model of menopause increases arterial stiffness in a similar manner to aging, and whether activation of the G protein-coupled estrogen receptor (GPER) could reverse stiffness. Female C57Bl/6J mice were ovariectomized (OVX) at 10 weeks of age or aged to 52 weeks, and some mice were treated with GPER agonists. OVX and aging increased pulse wave velocity to a similar extent independent of changes in blood pressure. Aging increased carotid wall thickness, while OVX increased material stiffness without altering vascular geometry. RNA-Seq analysis revealed that OVX downregulated smooth muscle contractile genes. The enantiomerically pure GPER agonist, LNS8801, reversed stiffness in OVX mice to a greater degree than the racemic agonist G-1. In summary, OVX and aging induced arterial stiffening via potentially different mechanisms. Aging was associated with inward remodeling while OVX induced material stiffness independent of geometry and a loss of the contractile phenotype. This study helps to further our understanding of the impact of menopause on vascular health and identifies LNS8801 as a potential therapy to counteract this detrimental process in women.
Competing Interest Statement
Christopher A. Natale is an employee and shareholder of Linnaeus Therapeutics Inc. and listed as inventor on patents related to this work.
Footnotes
Conflict of Interest: C.A.N. is an employee and shareholder of Linnaeus Therapeutics Inc. and listed as inventor on patents related to this work.
Funding: National Institutes of Health (HL155841 to B.O.O., HL133619 and AG071746 to S.H.L) and the American Heart Association Fellowships (559076 to B.V. and 559082 to I.K.).